Stay updated with breaking news from Johan Gil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced an update in the timing of the dose selection in the ongoing phase III study CONCLUDE...
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the Board of Directors has named Jenny Sundqvist as new CEO. Jenny comes from a...
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the company will be exhibiting at the United European Gastroenterology Week (UEGW)...
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the company has received positive feedback from the Japanese regulatory authority,...
STOCKHOLM, July 13, 2022 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod has been granted by the European